Apparatus and method for transmitting/receiving a signal in a mobile communication system using a multiple-input multiple-output scheme
    1.
    发明授权
    Apparatus and method for transmitting/receiving a signal in a mobile communication system using a multiple-input multiple-output scheme 有权
    使用多输入多输出方案在移动通信系统中发送/接收信号的装置和方法

    公开(公告)号:US07894544B2

    公开(公告)日:2011-02-22

    申请号:US11713545

    申请日:2007-03-02

    IPC分类号: H04L27/00 H04B7/02 H04L1/02

    CPC分类号: H04L1/0625 H04L1/0668

    摘要: In a communication system, a signal transceiver generates an upper pre-encoding symbol stream and a lower pre-encoding symbol stream by pre-encoding an upper transmission vector and a lower transmission vector according to a pre-encoding scheme when the upper and lower transmission vectors to be transmitted are input. The signal transceiver generates a space-time mapping matrix by space-time mapping the upper and lower pre-encoding symbol streams according to a space-time mapping scheme based on the number of transmit antennas to be used in the signal transceiver. The signal transceiver generates and transmits a codeword according to whether a null transmission is present in the space-time mapping matrix.

    摘要翻译: 在通信系统中,信号收发器通过根据预编码方案对上传输矢量和下传输矢量进行预编码,生成上预编码符号流和下预编码符号流,当上,下传输 要传输的矢量被输入。 信号收发器基于要在信号收发器中使用的发射天线的数量,根据空时映射方案,通过空时映射上和下预编码符号流来生成空时映射矩阵。 信号收发器根据空时映射矩阵中是否存在空传输来生成和发送码字。

    Apparatus and method for transmitting/receiving a signal in a mobile communication system using a multiple-input multiple-output scheme
    2.
    发明申请
    Apparatus and method for transmitting/receiving a signal in a mobile communication system using a multiple-input multiple-output scheme 有权
    使用多输入多输出方案在移动通信系统中发送/接收信号的装置和方法

    公开(公告)号:US20070223622A1

    公开(公告)日:2007-09-27

    申请号:US11713545

    申请日:2007-03-02

    IPC分类号: H04L27/00 H03D1/00

    CPC分类号: H04L1/0625 H04L1/0668

    摘要: In a communication system, a signal transceiver generates an upper pre-encoding symbol stream and a lower pre-encoding symbol stream by pre-encoding an upper transmission vector and a lower transmission vector according to a pre-encoding scheme when the upper and lower transmission vectors to be transmitted are input. The signal transceiver generates a space-time mapping matrix by space-time mapping the upper and lower pre-encoding symbol streams according to a space-time mapping scheme based on the number of transmit antennas to be used in the signal transceiver. The signal transceiver generates and transmits a codeword according to whether a null transmission is present in the space-time mapping matrix.

    摘要翻译: 在通信系统中,信号收发器通过根据预编码方案对上传输矢量和下传输矢量进行预编码,生成上预编码符号流和下预编码符号流,当上,下传输 要传输的矢量被输入。 信号收发器基于要在信号收发器中使用的发射天线的数量,根据空时映射方案,通过空时映射上和下预编码符号流来生成空时映射矩阵。 信号收发器根据空时映射矩阵中是否存在空传输来生成和发送码字。

    COMPOSITION FOR IN VIVO TRANSPLANTATION FOR TREATMENT OF HUMAN CERVICAL CANCER COMPRISING MONONUCLEAR CELLS DERIVED FROM UMBILICAL CORD BLOOD
    3.
    发明申请
    COMPOSITION FOR IN VIVO TRANSPLANTATION FOR TREATMENT OF HUMAN CERVICAL CANCER COMPRISING MONONUCLEAR CELLS DERIVED FROM UMBILICAL CORD BLOOD 审中-公开
    用于治疗包含来自脐带血单核细胞的人类癌症的体内移植物的组合物

    公开(公告)号:US20100068194A1

    公开(公告)日:2010-03-18

    申请号:US12312026

    申请日:2007-10-11

    申请人: Dong-Ku Kim

    发明人: Dong-Ku Kim

    IPC分类号: A61K45/00 A61P35/00

    CPC分类号: A61K35/44

    摘要: Provided is a composition for in vivo transplantation for the treatment of human cervical cancer, comprising mononuclear cells derived from umbilical cord blood and a pharmaceutically acceptable carrier. When the umbilical cord blood-derived mononuclear cells are transplanted in vivo, cervical cancer can be effectively treated. In particular, the mononuclear cells derived from the umbilical cord blood retain high differentiation and proliferation abilities and exhibit very low graft-versus-host (GVH) reactions which are side effects caused by transplantation, and thus, can be transplanted to many patients.

    摘要翻译: 本发明提供一种用于体内移植用于治疗人宫颈癌的组合物,其包含源自脐带血的单核细胞和药学上可接受的载体。 当脐带血衍生的单核细胞在体内移植时,可以有效治疗子宫颈癌。 特别地,源自脐带血的单核细胞具有高的分化和增殖能力,并且表现出非常低的移植物抗宿主(GVH)反应,这是由移植引起的副作用,因此可以移植到许多患者中。